Guideline | Organization | Published |
The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists | Canadian College of Medical Genetics | 2015 |
Updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing | American College of Medical Genetics and Genomics | 2015 |
Interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology | American College of Medical Genetics and Genomics,Association for Molecular Pathology | 2015 |
Genetic screening in the workplace | American College of Occupational and Environmental Medicine | 2015 |
Laboratory standards for next-generation sequencing clinical tests | College of American Pathologists | 2015 |
Informed consent for biobanking | Consensus conference | 2015 |
Position of the Academy of Nutrition and Dietetics: Nutritional genomics | Academy of Nutrition and Dietetics | 2014 |
Guidelines for return of research results from pediatric genomic studies: deliberations of the Boston Children's Hospital Gene Partnership Informed Cohort Oversight Board | Boston Children's Hospital Gene Partnership Informed Cohort Oversight Board | 2014 |
Prioritizing clinical genetic testing services | Consensus conference | 2014 |
Reporting results of diagnostic genetic testing (biochemical, cytogenetic and molecular genetic) | European Society of Human Genetics Genetic Services Quality Committee | 2014 |
Design, analysis and interpretation of 'omics' data: focus on human endometrium | Expert group | 2014 |
Ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts | Presidential Commission for the Study of Bioethical Issues | 2014 |
Ethical and policy issues in genetic testing and screening of children | American Academy of Pediatrics, American College of Medical Genetics and Genomics | 2013 |
Clinical laboratory standards for next-generation sequencing | American College of Medical Genetics and Genomics | 2013 |
Incidental findings in clinical genomics: a clarification | American College of Medical Genetics and Genomics | 2013 |
Reporting of incidental findings in clinical exome and genome sequencing | American College of Medical Genetics and Genomics | 2013 |
Risk categorization for oversight of laboratory-developed tests for inherited conditions | American College of Medical Genetics and Genomics | 2013 |
Early detection of prostate cancer | American Urological Association | 2013 |
Establishment of core competencies for canadian genetic counsellors: validation of practice based competencies | Canadian Association of Genetic Counsellors | 2013 |
Use of next-generation sequencing applications in genome diagnostics | Dutch Society for Clinical Genetic Laboratory Diagnostics | 2013 |
Direct-to-consumer genetic testing for health-related purposes | European Academies of Science Advisory Council, Federation of European Academies of Medicine | 2013 |
Whole-genome sequencing in health care | European Society of Human Genetics | 2013 |
Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration | Expert group | 2013 |
Informed consent for whole-genome sequencing studies in the clinical setting | Expert group | 2013 |
Stem cell research and therapy | National Society of Genetic Counselors | 2013 |
Direct-to-consumer genetic testing | Southern African Society for Human Genetics | 2013 |
Quality in genetic counselling for presymptomatic testing | UK expert group | 2013 |
Personalized genomic testing for disease risk | American College of Obstetricians and Gynecologists | 2012 |
Clinical diagnostic genome sequencing | Association for Molecular Pathology | 2012 |
Direct-to-consumer genetic testing for health-related purposes in the European Union | European Academies Scientific Advisory Council | 2012 |
No hay comentarios:
Publicar un comentario